Determination of the Drug Information Needs of the Medical Staff of a Nigerian Hospital following Implementation of Clinical Pharmacy Services

The types and frequency of questions asked of clinical pharmacists introducing clinical pharmacy services in the internal medicine wards of a Nigerian university hospital and the degree of compliance with pharmacists' recommendations were studied. Three faculty pharmacists collected data in two 30-working day study periods, separated by a year. Totals of 197 questions (an average of 6.57 ± 1.33 questions/working day) and 271 questions (an average of 9.03 ± 1.10 questions/working day) were answered by the pharmacists in the first and second study periods, respectively. Pharmacists recommended changes in patient-specific drug therapy that were implemented 52 percent and 69 percent of the time in the first and second study periods, respectively. The most common type of drug information request concerned the presence or the likelihood of an adverse drug reaction. Continuous interaction between pharmacists and physicians in the patient-care setting results in a better appreciation of the pharmacist's role as drug information consultant, and the consequence of this is a high degree of compliance with pharmacists' recommendations.

Download Full-text

Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital

BMC Health Services Research ◽

10.1186/s12913-022-07494-5 ◽

2022 ◽

Vol 22 (1) ◽

Author(s):

Aslınur Albayrak ◽

Bilgen Başgut ◽

Gülbin Aygencel Bıkmaz ◽

Bensu Karahalil

Keyword(s):

Intensive Care Unit ◽

Intensive Care ◽

Clinical Pharmacy ◽

Clinical Pharmacist ◽

University Hospital ◽

Pharmacy Services ◽

Drug Related Problems ◽

Electrolyte Disorders ◽

Drug Induced ◽

Clinical Pharmacy Services

Abstract Background Critically ill patients treated in the intensive care units (ICUs) often suffer from side effects and drug-related problems (DRPs) that can be life-threatening. A way to prevent DRPs and improve drug safety and efficacy is to include clinical pharmacists in the clinical team. This study aims to evaluate the classification of drug-related problems and the implementation of clinical pharmacy services by a clinical pharmacist in the ICU of a university hospital in Turkey. Methods This study was carried out prospectively between December 2020 and July 2021 in Gazi University Medical Faculty Hospital Internal Diseases ICU. All patients hospitalized in the intensive care unit for more than 24 h were included in the study. During the study, the clinical pharmacist's interventions and other clinical services for patients were recorded. DRPs were classed according to the Pharmaceutical Care Network Europe V.8.02. Results A total of 151 patients were included during the study period corresponding to 2264 patient-days. Patients with DRPs had a longer hospital stay and a higher mortality rate (p < 0.05). 108 patients had at least one DRP and the total number of DRPs was 206. There was an average of 1.36 DRPs per patient, 71.5% of patients experienced DRP and 89.22 DRPs per 1000 patient-days. A total of 35 ADEs were observed in 32 patients. ADE incidence was per 1000 patient-days 15.45. ADEs were caused by nephrotoxicity (48.57%), electrolyte disorders (17.14%), drug-induced thrombocytopenia (17.14%), liver enzyme increase (8.57%) and other causes (8.57%). Drug selection (40.29%) and dose selection (54.36%) constituted most of the causes of DRPs. Dose change was the highest percentage of planned interventions with a rate of 56.79%. Intervention was accepted at a rate of 90.8% and it was fully implemented. Conclusion In this study, the importance of the clinical pharmacist in the determination and analysis of DRPs was emphasized. Clinical pharmacy services like the one described should be implemented widely to increase patient safety.

Download Full-text

Introducing clinical pharmacy services to cardiovascular clinics at a university hospital in Northern Cyprus

International Journal of Clinical Pharmacy ◽

10.1007/s11096-017-0534-3 ◽

2017 ◽

Vol 39 (6) ◽

pp. 1185-1193 ◽

Cited By ~ 3

Author(s):

Haider Al-Baghdadi ◽

Çiğdem Koca Al-Baghdadi ◽

Abdikarim Abdi ◽

Onur Gültekin ◽

Arijana Meštrović ◽

...

Keyword(s):

Clinical Pharmacy ◽

University Hospital ◽

Pharmacy Services ◽

Clinical Pharmacy Services ◽

Northern Cyprus

Download Full-text

Implementing ward based clinical pharmacy services in an Ethiopian University Hospital

Pharmacy Practice ◽

10.4321/s1886-36552013000100009 ◽

2013 ◽

Vol 11 (1) ◽

pp. 51-57 ◽

Cited By ~ 22

Author(s):

Alemayehu B. Mekonnen ◽

Elias A. Yesuf ◽

Peggy S. Odegard ◽

Sultan S. Wega

Keyword(s):

Clinical Pharmacy ◽

University Hospital ◽

Pharmacy Services ◽

Clinical Pharmacy Services

Download Full-text

The role of the pharmacist in the multidisciplinary approach to the prevention and resolution of drug-related problems in cancer chemotherapy

Journal of Oncology Pharmacy Practice ◽

10.1177/1078155218786048 ◽

2018 ◽

Vol 25 (6) ◽

pp. 1312-1320 ◽

Cited By ~ 8

Author(s):

Ahmet S Boşnak ◽

Nevzat Birand ◽

Ömer Diker ◽

Abdikarim Abdi ◽

Bilgen Başgut

Keyword(s):

Clinical Pharmacy ◽

Treatment Effectiveness ◽

University Hospital ◽

Major Type ◽

Cancer Type ◽

Pharmacy Services ◽

Drug Related Problems ◽

Clinical Pharmacy Services ◽

Treatment Safety

Background Clinical pharmacists have important roles in implementing scientifically valid knowledge and advice on safe, reasonable use of pharmaceuticals. Clinical pharmacy services were introduced and evaluated in oncology clinic in a tertiary university hospital. Methods A prospective interventional study was conducted from November 2017 to March 2018. Drug-related problems were classified using the Pharmaceutical Care Network Europe drug-related problem classification tool v8.01. The main outcome measure is the proposed interventions aimed at identification of the drug-related problems, the role of the pharmacists in the resolution, and the rate of acceptance of these recommendations by physicians. Results A total of 102 patients were included in the study, who were treated with at least two cycles of any cancer type and stage. A total of 55 (53.9%) patients had 251 drug-related problems. Drug-related problems mainly involved antihypertensive (31.6%), antidiabetic (17.8%), and herbal agents (31.6%). Treatment effectiveness was the major type of drug-related problems (50.2%) followed by treatment safety (29.1%). A total of 211 (100%) interventions were accepted and regarded as clinically relevant. Prescriber informed only were the most common types of intervention at the prescriber level. Eighty-six point four percent identified drug-related problems were solved, 9.8% of the problems were partially solved, 2.3% problems were unsolved. Conclusion Clinical pharmacy services may have optimized therapy effectiveness, prevent adverse effects and unclear/compliant problems. The pharmacist interventions were highly acknowledged by oncologists and patients; this may indicate the presence of a great convenience and need to implement Clinical pharmacy services in alternative hospitals in Northern Cyprus.

Download Full-text

Impact of Introducing Clinical Pharmacy Services in A Respiratory Diseases Clinic: A Report from North Cyprus

Journal of Pharmaceutical Research International ◽

10.9734/jpri/2019/v29i630253 ◽

2019 ◽

pp. 1-15

Author(s):

Abdikarim Mohamed Abdi ◽

Finn Rasmussen ◽

Rumeysa Demirdamar

Keyword(s):

Clinical Pharmacy ◽

Respiratory Diseases ◽

University Hospital ◽

Baseline Survey ◽

Pharmacy Services ◽

High Expectations ◽

Clinical Pharmacy Services ◽

Clinical Pharmacists ◽

North Cyprus ◽

Classification Tool

Aims: The Implementation of Clinical Pharmacy Services (CPS) in hospitals is currently gaining attention in an effort to rationalize drug use in many developing countries. This study aims to introduce and evaluate ward-based CPS in a Respiratory Diseases clinic in North Cyprus and assess its efficacy and physician's perceptions toward the services. Study Design: A prospective interventional study. Place and Duration of Study: The study was carried out in the respiratory clinic from 01 December 2013, to 30 January 2014 at Near East University Hospital, in Nicosia, North Cyprus. Methodology: Clinical Pharmacy Services (CPS) were introduced and documented over the study period of 60 days in a tertiary university hospital. DTPs and Interventions were documented and classified using DTP classification tool obtained from previous studies, and later evaluated by an independent clinical committee for their feasibility. Physician’s attitudes and perceptions were evaluated before for and after introducing CPS's using a questionnaire tool. Results: 82.35% of the targeted physician's sample have responded to baseline survey, (n=17) majority (92%) did not have any previous interaction with clinical pharmacists, they generally well perceived and had high expectations to pharmaceutical care services in general. This further enhanced the post-implementation of CPS. 118 interventions were carried during the program, 86.6% accepted and regarded as clinically relevant. Interventions mostly related to cardiovascular agents. Add/ change/stop medications were the most common type of interventions (21%). Most common resultant outcome was to avoid adverse effects or toxicities. The intervention was significantly related to the number of drugs used (r=0,487; p=0,006), the rate of acceptance significantly was higher to services compared to DRP interventions (p<0.005). Conclusion: The introduction of CPS's lead to clinically relevant and highly accepted optimization of medicine use in different wards and clinics including respiratory diseases clinic in the case of this study, it was relatively well perceived by physicians, but also could be more valued if more optimized and practiced by talented proactive clinical pharmacists within a multidisciplinary team.

Download Full-text